Literature DB >> 25574827

HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy.

Hanna M Ollila1, Jean-Marie Ravel1, Fang Han2, Juliette Faraco1, Ling Lin1, Xiuwen Zheng3, Giuseppe Plazzi4, Yves Dauvilliers5, Fabio Pizza4, Seung-Chul Hong6, Poul Jennum7, Stine Knudsen8, Birgitte R Kornum9, Xiao Song Dong2, Han Yan2, Heeseung Hong1, Cristin Coquillard10, Joshua Mahlios1, Otto Jolanki1, Mali Einen1, Isabelle Arnulf, Sophie Lavault11, Birgit Högl12, Birgit Frauscher12, Catherine Crowe13, Markku Partinen14, Yu Shu Huang15, Patrice Bourgin16, Outi Vaarala17, Alex Désautels18, Jacques Montplaisir19, Steven J Mack20, Michael Mindrinos21, Marcelo Fernandez-Vina10, Emmanuel Mignot22.   

Abstract

Type 1 narcolepsy, a disorder caused by a lack of hypocretin (orexin), is so strongly associated with human leukocyte antigen (HLA) class II HLA-DQA1(∗)01:02-DQB1(∗)06:02 (DQ0602) that very few non-DQ0602 cases have been reported. A known triggering factor for narcolepsy is pandemic 2009 influenza H1N1, suggesting autoimmunity triggered by upper-airway infections. Additional effects of other HLA-DQ alleles have been reported consistently across multiple ethnic groups. Using over 3,000 case and 10,000 control individuals of European and Chinese background, we examined the effects of other HLA loci. After careful matching of HLA-DR and HLA-DQ in case and control individuals, we found strong protective effects of HLA-DPA1(∗)01:03-DPB1(∗)04:02 (DP0402; odds ratio [OR] = 0.51 [0.38-0.67], p = 1.01 × 10(-6)) and HLA-DPA1(∗)01:03-DPB1(∗)04:01 (DP0401; OR = 0.61 [0.47-0.80], p = 2.07 × 10(-4)) and predisposing effects of HLA-DPB1(∗)05:01 in Asians (OR = 1.76 [1.34-2.31], p = 4.71 × 10(-05)). Similar effects were found by conditional analysis controlling for HLA-DR and HLA-DQ with DP0402 (OR = 0.45 [0.38-0.55] p = 8.99 × 10(-17)) and DP0501 (OR = 1.38 [1.18-1.61], p = 7.11 × 10(-5)). HLA-class-II-independent associations with HLA-A(∗)11:01 (OR = 1.32 [1.13-1.54], p = 4.92 × 10(-4)), HLA-B(∗)35:03 (OR = 1.96 [1.41-2.70], p = 5.14 × 10(-5)), and HLA-B(∗)51:01 (OR = 1.49 [1.25-1.78], p = 1.09 × 10(-5)) were also seen across ethnic groups in the HLA class I region. These effects might reflect modulation of autoimmunity or indirect effects of HLA class I and HLA-DP alleles on response to viral infections such as that of influenza.
Copyright © 2015 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25574827      PMCID: PMC4289679          DOI: 10.1016/j.ajhg.2014.12.010

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  57 in total

1.  Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.

Authors:  I Persson; F Granath; J Askling; J F Ludvigsson; T Olsson; N Feltelius
Journal:  J Intern Med       Date:  2013-11-10       Impact factor: 8.989

2.  DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe.

Authors:  Mehdi Tafti; Hyun Hor; Yves Dauvilliers; Gert J Lammers; Sebastiaan Overeem; Geert Mayer; Sirous Javidi; Alex Iranzo; Joan Santamaria; Rosa Peraita-Adrados; José L Vicario; Isabelle Arnulf; Giuseppe Plazzi; Sophie Bayard; Francesca Poli; Fabio Pizza; Peter Geisler; Aleksandra Wierzbicka; Claudio L Bassetti; Johannes Mathis; Michel Lecendreux; Claire E H M Donjacour; Astrid van der Heide; Raphaël Heinzer; José Haba-Rubio; Eva Feketeova; Birgit Högl; Birgit Frauscher; Antonio Benetó; Ramin Khatami; Francesca Cañellas; Corinne Pfister; Sabine Scholz; Michel Billiard; Christian R Baumann; Guadalupe Ercilla; Willem Verduijn; Frans H J Claas; Valérie Dubois; Jacek Nowak; Hans-Peter Eberhard; Sylvain Pradervand; Charlotte N Hor; Manuela Testi; Jean-Marie Tiercy; Zoltán Kutalik
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

3.  Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.

Authors:  Yves Dauvilliers; Isabelle Arnulf; Michel Lecendreux; Christelle Monaca Charley; Patricia Franco; Xavier Drouot; Marie-Pia d'Ortho; Sandrine Launois; Séverine Lignot; Patrice Bourgin; Béatrice Nogues; Marc Rey; Sophie Bayard; Sabine Scholz; Sophie Lavault; Pascale Tubert-Bitter; Cristel Saussier; Antoine Pariente
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

4.  HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.

Authors:  T-W Wu; C-C Chu; H-W Chang Liao; S-K Lin; T-Y Ho; M Lin; H H Lin; L-Y Wang
Journal:  Genes Immun       Date:  2013-11-28       Impact factor: 2.676

5.  Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A.

Authors:  M S Heier; K M Gautvik; E Wannag; K H Bronder; E Midtlyng; Y Kamaleri; J Storsaeter
Journal:  Sleep Med       Date:  2013-06-14       Impact factor: 3.492

6.  Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic.

Authors:  Fang Han; Juliette Faraco; Xiao Song Dong; Hanna M Ollila; Ling Lin; Jing Li; Pei An; Shan Wang; Ke Wei Jiang; Zhan Cheng Gao; Long Zhao; Han Yan; Ya Nan Liu; Qing Hua Li; Xiao Zhe Zhang; Yan Hu; Jing Yu Wang; Yun Hui Lu; Chang Jun Lu; Wei Zhou; Joachim Hallmayer; Yu Shu Huang; Kingman P Strohl; Thomas Pollmächer; Emmanuel Mignot
Journal:  PLoS Genet       Date:  2013-10-31       Impact factor: 5.917

7.  Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects.

Authors:  Nikolaos A Patsopoulos; Lisa F Barcellos; Rogier Q Hintzen; Catherine Schaefer; Cornelia M van Duijn; Janelle A Noble; Towfique Raj; Pierre-Antoine Gourraud; Barbara E Stranger; Jorge Oksenberg; Tomas Olsson; Bruce V Taylor; Stephen Sawcer; David A Hafler; Mary Carrington; Philip L De Jager; Paul I W de Bakker
Journal:  PLoS Genet       Date:  2013-11-21       Impact factor: 5.917

8.  Diversity of extended HLA-DRB1 haplotypes in the Finnish population.

Authors:  Annika Wennerström; Efthymia Vlachopoulou; L Elisa Lahtela; Riitta Paakkanen; Katja T Eronen; Mikko Seppänen; Marja-Liisa Lokki
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

9.  New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia.

Authors:  Nao Nishida; Hiromi Sawai; Koichi Kashiwase; Mutsuhiko Minami; Masaya Sugiyama; Wai-Kay Seto; Man-Fung Yuen; Nawarat Posuwan; Yong Poovorawan; Sang Hoon Ahn; Kwang-Hyub Han; Kentaro Matsuura; Yasuhito Tanaka; Masayuki Kurosaki; Yasuhiro Asahina; Namiki Izumi; Jong-Hon Kang; Shuhei Hige; Tatsuya Ide; Kazuhide Yamamoto; Isao Sakaida; Yoshikazu Murawaki; Yoshito Itoh; Akihiro Tamori; Etsuro Orito; Yoichi Hiasa; Masao Honda; Shuichi Kaneko; Eiji Mita; Kazuyuki Suzuki; Keisuke Hino; Eiji Tanaka; Satoshi Mochida; Masaaki Watanabe; Yuichiro Eguchi; Naohiko Masaki; Kazumoto Murata; Masaaki Korenaga; Yoriko Mawatari; Jun Ohashi; Minae Kawashima; Katsushi Tokunaga; Masashi Mizokami
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

10.  Imputing amino acid polymorphisms in human leukocyte antigens.

Authors:  Xiaoming Jia; Buhm Han; Suna Onengut-Gumuscu; Wei-Min Chen; Patrick J Concannon; Stephen S Rich; Soumya Raychaudhuri; Paul I W de Bakker
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more
  39 in total

1.  Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.

Authors:  Kathryn Edwards; Germaine Hanquet; Steve Black; Emmanuel Mignot; Christopher Jankosky; Tom Shimabukuro; Elizabeth Miller; Hanna Nohynek; Pieter Neels
Journal:  Biologicals       Date:  2019-05-23       Impact factor: 1.856

Review 2.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

Review 3.  Narcolepsy Associated with Pandemrix Vaccine.

Authors:  Tomi Sarkanen; Anniina Alakuijala; Ilkka Julkunen; Markku Partinen
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-01       Impact factor: 5.081

4.  Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity.

Authors:  Mehdi Tafti; Gert J Lammers; Yves Dauvilliers; Sebastiaan Overeem; Geert Mayer; Jacek Nowak; Corinne Pfister; Valérie Dubois; Jean-François Eliaou; Hans-Peter Eberhard; Roland Liblau; Aleksandra Wierzbicka; Peter Geisler; Claudio L Bassetti; Johannes Mathis; Michel Lecendreux; Ramin Khatami; Raphaël Heinzer; José Haba-Rubio; Eva Feketeova; Christian R Baumann; Zoltán Kutalik; Jean-Marie Tiercy
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

5.  A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia.

Authors:  Taku Miyagawa; Seik-Soon Khor; Hiromi Toyoda; Takashi Kanbayashi; Aya Imanishi; Yohei Sagawa; Nozomu Kotorii; Tatayu Kotorii; Yu Ariyoshi; Yuji Hashizume; Kimihiro Ogi; Hiroshi Hiejima; Yuichi Kamei; Akiko Hida; Masayuki Miyamoto; Azusa Ikegami; Yamato Wada; Masanori Takami; Yuichi Higashiyama; Ryoko Miyake; Hideaki Kondo; Yota Fujimura; Yoshiyuki Tamura; Yukari Taniyama; Naoto Omata; Yuji Tanaka; Shunpei Moriya; Hirokazu Furuya; Mitsuhiro Kato; Yoshiya Kawamura; Takeshi Otowa; Akinori Miyashita; Hiroto Kojima; Hiroh Saji; Mihoko Shimada; Maria Yamasaki; Takumi Kobayashi; Rumi Misawa; Yosuke Shigematsu; Ryozo Kuwano; Tsukasa Sasaki; Jun Ishigooka; Yuji Wada; Kazuhito Tsuruta; Shigeru Chiba; Fumiaki Tanaka; Naoto Yamada; Masako Okawa; Kenji Kuroda; Kazuhiko Kume; Koichi Hirata; Naohisa Uchimura; Tetsuo Shimizu; Yuichi Inoue; Yutaka Honda; Kazuo Mishima; Makoto Honda; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2018-09-28       Impact factor: 3.172

6.  Clinical update sleep: year in review 2015-2016.

Authors:  Culadeeban Ratneswaran; Jameel Mushtaq; Joerg Steier
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

Review 7.  Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Authors:  Lucie Barateau; Roland Liblau; Christelle Peyron; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

Review 8.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

Review 9.  Immunotherapy in Narcolepsy.

Authors:  Maria Pia Giannoccaro; Giombattista Sallemi; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Curr Treat Options Neurol       Date:  2020-01-30       Impact factor: 3.598

10.  CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice.

Authors:  Raphaël Bernard-Valnet; Lidia Yshii; Clémence Quériault; Xuan-Hung Nguyen; Sébastien Arthaud; Magda Rodrigues; Astrid Canivet; Anne-Laure Morel; Arthur Matthys; Jan Bauer; Béatrice Pignolet; Yves Dauvilliers; Christelle Peyron; Roland S Liblau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.